BioCentury
ARTICLE | Clinical News

rNAPc2: Phase II started

January 8, 2007 8:00 AM UTC

NUVO began a placebo-controlled, dose-escalation Phase II trial of rNAPc2 in combination with 5-fluorouracil (5-FU) in 100 patients. ...